Results 31 to 40 of about 1,747,273 (202)

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

Nature Communications, 2022
Non-pharmaceutical interventions for COVID-19 also reduced incidence of respiratory pathogens such as respiratory syncytial virus (RSV). Here, the authors report the resurgence of RSV in Australia following lifting of some of the restrictions and ...
John-Sebastian Eden, Chisha Sikazwe, Ruopeng Xie, Yi-Mo Deng, Sheena G. Sullivan, Alice Michie, Avram Levy, Elena Cutmore, Christopher C. Blyth, Philip N. Britton, Nigel Crawford, Xiaomin Dong, Dominic E. Dwyer, Kimberly M. Edwards, Bethany A. Horsburgh, David Foley, Karina Kennedy, Cara Minney-Smith, David Speers, Rachel L. Tulloch, Edward C. Holmes, Vijaykrishna Dhanasekaran, David W. Smith, Jen Kok, Ian G. Barr, the Australian RSV study group   +25 more
doaj   +1 more source

Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA

Emerging Infectious Diseases, 2023
We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022–April 2023 in Arizona, USA.
LaRinda A. Holland, Steven C. Holland, Matthew F. Smith, Victoria R. Leonard, Vel Murugan, Lora Nordstrom, Mary Mulrow, Raquel Salgado, Michael White, Efrem S. Lim   +9 more
doaj   +1 more source

Respiratory syncytial virus and Streptococcus pneumoniae Co-infection in an elderly individual within a familial cluster

Journal of Medical Sciences, 2023
Respiratory syncytial virus (RSV) is a common pathogen that causes respiratory tract infection and has been found to co-infect with other bacteria. Although the virus can cause morbidity and mortality in the elderly, RSV-bacteria co-infection had rarely ...
Ju-Chien Hsueh, Der-Ming Chu, Feng-Yee Chang, Yung-Chih Wang   +3 more
doaj   +1 more source

Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom. [PDF]

, 2006
Respiratory syncytial virus (RSV) infection produces more severe disease and increased hospitalization rates in high-risk babies. The monoclonal antibody palivizumab offers protection against complications, and the first of five monthly doses should be ...
Nguyen-Van-Tam, JS, M. C. Cooke, J. S. Nguyen-van-tam, R. K. Gupta, Gupta, RK, Goddard, NL, N. L. Goddard, Cooke, MC   +7 more
core   +1 more source

CD25(+) Natural Regulatory T Cells Are Critical in Limiting Innate and Adaptive Immunity and Resolving Disease following Respiratory Syncytial Virus Infection [PDF]

, 2010
Regulatory CD4(+) T cells have been shown to be important in limiting immune responses, but their role in respiratory viral infections has received little attention.
Harker, JA, Johansson, C, Cecilia Johansson, Tregoning, John S, Jürgen Schwarze, Atabani, Sowsan F, Lee, Debbie C P, Atabani, SF, Lee, DC, Harker, James A E, Peter J. M. Openshaw, Schwarze, J, Harker, JAE, James A. E. Harker, Openshaw, Peter J M, Tregoning, JS, Lee, DCP, Johansson, Cecilia, John S. Tregoning, Openshaw, PJ, Schwarze, Jürgen, Openshaw, PJM, Debbie C. P. Lee, Sowsan F. Atabani   +23 more
core   +1 more source

Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. [PDF]

, 2002
Estimates of the number of hospitalizations attributable to specific pathogens are required to predict the potential impact of vaccination. All hospital admissions for lower respiratory tract infection (LRI) in children < 5 years in England in 1995-8 ...
Edmunds, WJ, Gay, NJ, Crowcroft, NS, Zambon, MC, Müller-Pebody, B   +4 more
core   +1 more source

Isolation of respiratory syncytial virus from nasopharyngeal aspirates stored at 20ºC from one to fifteen months after collection

Memorias do Instituto Oswaldo Cruz, 2006
Cell culture isolation is used for recovering respiratory syncytial virus (RSV) from respiratory specimens. As RSV is a thermolabile virus, specimens destined for inoculation into cell culture require special transport, handling, and storage.
IFS Nunes, FEA Moura
doaj   +1 more source

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)

Pathogens, 2023
Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease, especially in young children. Despite its global impact on healthcare, related to its high prevalence and its association with significant morbidity, the current therapy is still mostly supportive.
Dvir Gatt, Isaac Martin, Rawan AlFouzan, Theo J. Moraes   +3 more
openaire   +3 more sources

The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children

Cell Reports Medicine
Summary: Respiratory syncytial virus (RSV) is the leading cause of infant respiratory infections and hospitalizations. To investigate the relationship between the respiratory microbiome and RSV infection, we sequence nasopharyngeal samples from a birth ...
Maartje Kristensen, Wouter A.A. de Steenhuijsen Piters, Joanne Wildenbeest, Marlies A. van Houten, Roy P. Zuurbier, Raiza Hasrat, Kayleigh Arp, Mei Ling J.N. Chu, Marie Billard, Terho Heikkinen, Steve Cunningham, Matthew Snape, Simon B. Drysdale, Ryan S. Thwaites, Federico Martinon-Torres, Andrew J. Pollard, Peter J.M. Openshaw, Jeroen Aerssens, Justyna Binkowska, Louis Bont, Debby Bogaert   +20 more
doaj   +1 more source

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection [PDF]

, 2005
Human respiratory syncytial virus (hRSV) transmission dynamics are inherently cyclical, and the observed genetic diversity (between groups A and B) also appears to have a repeating pattern.
Waris, M, White, Lisa, Medley, GF, White, L. J., Medley, Graham, Waris, M., Cane, Patricia, Nokes, D. James, Nokes, DJ, White, LJ, Cane, PA   +10 more
core   +1 more source